» Articles » PMID: 38863827

Genetics, Pharmacotherapy, and Dietary Interventions in Childhood Obesity

Overview
Specialties Pharmacology
Pharmacy
Date 2024 Jun 12
PMID 38863827
Authors
Affiliations
Soon will be listed here.
Abstract

Childhood obesity has emerged as a major global health issue, contributing to the increased prevalence of chronic conditions and adversely affecting the quality of life and future prospects of affected individuals, thereby presenting a substantial societal challenge. This complex condition, influenced by the interplay of genetic predispositions and environmental factors, is characterized by excessive energy intake due to uncontrolled appetite regulation and a Westernized diet. Managing obesity in childhood requires specific considerations compared with adulthood, given the vulnerability of the critical juvenile-adolescent period to toxicity and developmental defects. Consequently, common treatment options for adult obesity may not directly apply to younger populations. Therefore, research on childhood obesity has focused on genetic defects in regulating energy intake, alongside pharmacotherapy and dietary interventions as management approaches, with an emphasis on safety concerns. This review aims to summarize canonical knowledge and recent findings on genetic factors contributing to childhood obesity. Additionally, it assesses the efficacy and safety of existing pharmacotherapies and dietary interventions and suggests future research directions. By providing a comprehensive understanding of the complex dynamics of childhood obesity, this review aims to offer insights into more targeted and effective strategies for addressing this condition, including personalized healthcare solutions.

Citing Articles

Childhood obesity in South Asian population.

Pahuja V, Sanghvi S Obes Pillars. 2024; 12:100148.

PMID: 39734696 PMC: 11681364. DOI: 10.1016/j.obpill.2024.100148.

References
1.
Leow Z, Guelfi K, Davis E, Jones T, Fournier P . The glycaemic benefits of a very-low-carbohydrate ketogenic diet in adults with Type 1 diabetes mellitus may be opposed by increased hypoglycaemia risk and dyslipidaemia. Diabet Med. 2018; . DOI: 10.1111/dme.13663. View

2.
Kwiterovich Jr P, Vining E, Pyzik P, Skolasky Jr R, Freeman J . Effect of a high-fat ketogenic diet on plasma levels of lipids, lipoproteins, and apolipoproteins in children. JAMA. 2003; 290(7):912-20. DOI: 10.1001/jama.290.7.912. View

3.
Mishra A, Mirzaei H, Guidi N, Vinciguerra M, Mouton A, Linardic M . Fasting-mimicking diet prevents high-fat diet effect on cardiometabolic risk and lifespan. Nat Metab. 2021; 3(10):1342-1356. DOI: 10.1038/s42255-021-00469-6. View

4.
Vourdoumpa A, Paltoglou G, Charmandari E . The Genetic Basis of Childhood Obesity: A Systematic Review. Nutrients. 2023; 15(6). PMC: 10058966. DOI: 10.3390/nu15061416. View

5.
Clement K, van den Akker E, Argente J, Bahm A, Chung W, Connors H . Efficacy and safety of setmelanotide, an MC4R agonist, in individuals with severe obesity due to LEPR or POMC deficiency: single-arm, open-label, multicentre, phase 3 trials. Lancet Diabetes Endocrinol. 2020; 8(12):960-970. DOI: 10.1016/S2213-8587(20)30364-8. View